Marc Ullman was cited in the NutraIngredientsUSA article, “FDA’s takedown of NMN raises fairness transparency concerns.”

The FDA has disallowed the anti-aging ingredient, NMN, and this has raised questions of fairness and transparency.

Ullman said the current FDA interpretation sets up a situation in which a pharma company could file an IND, let the issue

Rivkin Radler is pleased to announce that the Firm has been named to the U.S. News – Best Lawyers “Best Law Firms” list for 2023. The Firm was ranked in the following regions and practice areas:

Metropolitan Tier 1

Albany: Commercial Litigation, Health Care Law

Long Island: Elder Law, Health Care Law, Insurance Law, Litigation-Health Care,

Please join us for the November Lunch and Learn as Rivkin Radler Partners John Diviney and Tamika Hardy discuss the following topics:

• New State laws – New York Marijuana Regulation and Taxation Act, New York Labor Law Section 201-D, New York Human Rights Law, New York Penal Law, New York City Administrative Code
• Pre-employment

Please join us for the October Lunch and Learn as we discuss:

– Identifying whether you have an overpayment or potential fraud liability
– Determining when and where to disclose
– Tips for setting yourself up for a successful outcome

The program will be presented and moderated by Robert Hussar, a partner in

Jeff Ehrhardt recently published a column collecting a compendium of citations to recent and trending topics in health law journals for the New York State Bar Association Health Law Journal.

The compendium can be found here.

The journal is available here.

Geoffrey Kaiser will be presenting “Use of the False Claims in Health Care Fraud Investigations and Litigation” at the Upstate New York Health Care Fraud Symposium, hosted by the United States Attorney’s Office For The Northern District of New York.

The event will take place on Friday, September 30, 2022, at Albany Law School, in

Marc Ullman was quoted in the NutraIngredientsUSA article, “Amazon warning over skin tag products puts online giant on notice for assuring regulatory compliance.”

The article explains that the FDA issued a warning letter to Amazon for two marketers whose products are sold on Amazon’s site. These products claim to remove skin tags, but are not

Please join us as Rivkin Radler Associate Ashley Algazi presents the September Lunch and Learn. The program will:

• Review HIPAA breach definition
• Discuss the analysis and investigation process to determine if a breach has occurred
• Review exceptions to the definition of ‘breach’
• Discuss covered entity vs business associate

On July 13, the Office of Medicaid Inspector General (OMIG) published proposed regulations implementing 2020 changes to law relating to provider compliance programs, Medicaid managed care fraud, waste and abuse prevention programs, and OMIG’s self-disclosure program. The proposed changes will significantly impact both payers and providers alike.

Hear from Robert Hussar, a compliance professional and

On September 28, 2022, Jeff Kaiser will be a panelist at the Practising Law Institute’s program, Life Sciences 2022: Navigating Legal Challenges in Drug and Device Industries. The program is designed for attorneys and allied professionals who counsel pharmaceutical and life sciences companies.

Entitled “Enforcement Trends Impacting the Drug and Device Industries,” Jeff’s panel will